Non-gonococcal urethritis
Conditions
Interventions
Garenoxacin 400mg once daily p.o. 7days
Sponsors
Jikei university katsushika medical center,Department of urology
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Outpatients with non-gonococcal urethritis over 20 years old. Patients who undersutand the study and agree with written informed consent. Ptients agree that they do not have sexual intercourse without using condom during the period of clinical trial.
Exclusion criteria
Exclusion criteria: Patient with a history of allergies against fluoroquinolone. Patient with convulsive disorders like epilepsy or with a history of these deseases. Patients who have severe heart diseases including inchemic heart diseases or arrthythmia. Patient with diabetis mellitus. Patient with systolic blood pressure of patients below 90mmHg. Patient with myasthenia gravis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbiological efficacy of GRNX against causative bacteria(mMycoplasma genitalium,Chlamydaia trachomatis,Ureaplasma urealyticum)is investigated in non-gonococcal urethritis. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the clinical efficacies of GRNX to non-gonococcal urethritis | — |
Countries
Japan
Contacts
Public ContactHiroshi kiyota
Jikei university katsushika medical center Department of urology
Outcome results
None listed